Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

Can Payment Be Prorated Based on How Much of the Study a Participant Completes?

Research reimbursement and compensation can generally be prorated according to expenses incurred and participation completed. Proration should reflect what participants have actually contributed, not operate as a penalty for withdrawing.

197
Prorating Participant Payment Guide 197 of 398
01 · The Question

Can You Pay Participants Only for the Portion of a Study They Complete?

A participant completes six of ten study sessions. Should they receive 60% of the payment?

Often, some form of proration is appropriate. But the arithmetic is not always as simple as multiplying the total payment by the percentage of the study completed.

Different visits may take different amounts of time. Participants may incur different expenses. Some procedures may be more burdensome than others. A study may also include a genuine completion incentive that serves a different purpose from ordinary compensation.

Proration works best when it follows the underlying payment rationale rather than treating every study as ten identical slices of one total amount.

02 · The Short Answer

Yes, and Proration Is Often the Preferred Approach

In Brief

Yes. Reimbursement and compensation can generally be prorated according to expenses incurred and participation completed, and U.S. OHRP, FDA, and SACHRP guidance favors accrual or proration rather than making all ordinary payment contingent on completing an entire multi-stage study.

Proration should correspond to the payment's purpose. A genuine completion incentive may legitimately depend on reaching a specified endpoint, whereas reimbursement for incurred costs and compensation for completed participation should ordinarily accrue as those costs and contributions occur.

03 · What You Need to Know

Proration Is About Accruing Payment Fairly, Not Punishing Incompletion

Why Ethics Guidance Favors Proration

A participant's right to withdraw creates a basic problem with all-or-nothing payment.

If someone must finish every visit to receive compensation for any of them, leaving the study becomes financially costly. The participant may remain not because continued participation is personally acceptable, but because withdrawal would erase compensation associated with substantial participation already completed.

OHRP therefore recommends prorating payment for time spent in studies of considerable duration or involving multiple interactions or interventions. FDA similarly states that payment credit should accrue as the study progresses rather than depending on completion of the entire study.

Proration Does Not Always Mean a Simple Percentage

Suppose a ten-visit study offers $500 total compensation. A participant completes five visits. Is the correct payment automatically $250?

Only if those visits genuinely represent equal units of compensable participation.

If Visits 1 through 4 take thirty minutes each while Visit 5 takes four hours, a simple per-visit division may poorly reflect the participant's actual contribution. Likewise, travel expenses may differ across visits.

Mechanical proration Divide the total payment evenly by the number of visits regardless of what each visit requires.
Rationale-based proration Assign payment according to the time, activities, burdens, expenses, or other prospectively defined basis associated with each stage.

The second approach generally makes the payment rationale easier to defend.

Reimbursement Should Follow Costs Actually Incurred

Reimbursement is not naturally prorated according to a study-completion percentage. It follows expenses.

If a participant completes 50% of a study but has already incurred 70% of their approved transportation expenses, reimbursing exactly 50% of a maximum travel allowance may not reflect what actually happened.

SACHRP recommends that reimbursement accrue with the costs participants incur and notes that reimbursement can vary among participants according to their actual qualifying expenses.

Payment component Useful basis for proration Example
Travel reimbursement Approved expenses actually incurred Eligible transport cost for each completed visit
Time-based compensation Time or study activities completed Compensation assigned to each interview or visit
Burden-based compensation Prospectively defined procedures or activities Different approved amounts for substantially different study procedures
Completion incentive Defined completion milestone Separate bonus for completing the final scheduled assessment

Compensation Should Follow Contributions Already Made

SACHRP's rationale for prorating compensation is that participants contribute time and accept research-related burdens as the study progresses. Those contributions are not retroactively cancelled when participation ends early.

A useful payment schedule can therefore assign amounts to meaningful units of participation: individual visits, blocks of sessions, interviews, specimen collections, diary periods, assessments, or study phases.

OHRP gives concrete examples. A six-month study might pay monthly or every two months. A twelve-session study might pay after every two sessions.

Proration Protects the Right to Withdraw

The ethical value of proration is not merely accounting convenience.

If participants know that completed participation remains compensated, the financial cost of exercising the right to withdraw is reduced. OHRP explicitly connects its recommendation for proration to avoiding undue influence on decisions about withdrawal.

SACHRP similarly argues that making reimbursement and compensation contingent on full completion is inappropriate because it changes those payments into incentives for retention.

Watch Out

Do not design "proration" so that nearly all meaningful compensation is assigned to the final visit. Formally dividing payment across stages does little to protect withdrawal if the schedule is deliberately back-loaded without a defensible reason.

A Completion Incentive Does Not Have to Be Prorated in the Same Way

A genuine incentive is different because its purpose may be precisely to encourage participants to reach a particular endpoint.

SACHRP recommends proration for reimbursement and compensation but does not recommend requiring the same treatment for incentives. A completion bonus may be legitimate because the value of the incentive is tied to reaching the study's finish line rather than repaying costs or compensating contributions that accrue continuously.

FDA similarly permits a small proportion of overall payment as a reasonable completion incentive, provided it is not so large that it unduly induces participants to remain when they otherwise would withdraw.

This is why researchers should first distinguish compensation, reimbursement, and incentives before deciding what to prorate.

Prorated Payment Can Be Accrued Now and Paid Later

Researchers sometimes assume that proration requires dozens of small transactions. It does not.

FDA allows payment to a withdrawing participant on the date they would otherwise have completed the study or study phase when delayed disbursement does not create undue inconvenience or a coercive practice. SACHRP likewise acknowledges that administrative constraints can justify holding prorated amounts until a later payment date.

What matters ethically is that the participant's accrued amount is preserved rather than made conditional on continued participation.

Proration Can Follow Milestones Rather Than Minutes

Not every study needs an hourly meter running in the background.

A questionnaire study might assign compensation to each survey wave. A longitudinal study could pay after each monthly assessment. A clinical study might associate compensation with particular visits. A qualitative project might assign a separate amount to the interview and follow-up member-checking activity.

The units should correspond reasonably to what participants are asked to do.

Different Stages Can Have Different Values

Proration does not require equal payment per visit.

SACHRP recognizes that compensation may differ when participants contribute different amounts of time or undertake different burdens, such as more extensive or uncomfortable study visits.

A four-hour procedure can therefore carry more compensation than a twenty-minute follow-up without violating the principle of proration. In fact, assigning identical amounts despite dramatically different demands may be harder to justify.

Proration Should Be Defined Before Participants Enroll

A payment schedule becomes ethically questionable when researchers decide the value of partial participation only after someone withdraws.

Participants should be able to understand what they will receive for each relevant stage and what happens if they stop. FDA requires payment amount and schedule information to appear in the informed consent document, while SACHRP emphasizes clear disclosure of timing and conditions.

Prospective rules also reduce disputes and prevent researchers from valuing incomplete participation according to whether the resulting data happen to be useful.

04 · A Practical Example

Prorating a Five-Stage Study Without Simply Dividing by Five

Hypothetical Example

A Study With Unequal Activities

A study has five stages. The research team determines compensation prospectively according to the expected time and burden of each activity rather than dividing one total evenly across five stages.

Stage 1 A short screening and baseline assessment carries $20 in compensation.
Stage 2 A lengthy laboratory visit carries $80 because it requires considerably more time and inconvenience.
Stage 3 A brief remote follow-up carries $20.
Stage 4 A second lengthy laboratory visit carries $80.
Stage 5 A final assessment carries $30, with a separately identified reasonable completion incentive if approved.
Early withdrawal A participant who stops after Stage 3 retains or receives the compensation accrued for Stages 1–3 plus any qualifying reimbursement, rather than simply receiving three-fifths of every possible payment component.

This is still proration. It is simply based on the structure of actual participation rather than pretending that every stage imposes the same burden.

05 · What Researchers Often Get Wrong

Common Mistakes When Prorating Participant Payment

Misconception

Does Proration Always Mean Paying the Percentage of the Study Completed?

No. A percentage can work when study units are genuinely comparable, but different activities may justify different amounts. Reimbursement should also follow qualifying expenses rather than an arbitrary completion percentage.

Misconception

Can Researchers Put Most of the Payment at the End and Still Call It Prorated?

A heavily back-loaded schedule needs a defensible rationale. If ordinary compensation for earlier contributions is effectively withheld until completion, the structure can undermine the purpose of proration and create pressure against withdrawal.

Misconception

Must Every Completion Bonus Be Prorated?

No. SACHRP specifically distinguishes genuine incentives from reimbursement and compensation and does not recommend mandatory proration of incentives. A reasonable completion bonus may depend on completion, subject to safeguards against undue influence.

Misconception

Does Proration Mean Researchers Must Pay After Every Single Activity?

No. Payment can accrue through completed participation while actual disbursement occurs periodically or, in appropriate short studies, at a later scheduled date. OHRP and FDA allow practical payment schedules provided they do not improperly pressure continued participation.

Misconception

Can Researchers Decide the Prorated Amount After Someone Withdraws?

Payment conditions should normally be established prospectively and disclosed during consent. Retroactively deciding that completed participation is worth less because a participant withdrew creates obvious fairness problems and can make payment depend on investigator discretion rather than the approved study plan.

06 · What This Means for You

Build Payment Around Units of Participation

A good prorated schedule begins by identifying the meaningful units through which costs and participant contributions accrue.

A practical proration framework

If the payment reimburses an expense
Tie it to qualifying costs actually incurred rather than a generic percentage of study completion.
If compensation recognizes time or burden
Assign defensible amounts to visits, activities, periods, or milestones according to what each requires.
If all study units are genuinely comparable
A simple proportional calculation may be appropriate.
If study activities differ substantially
Use activity-based proration rather than mechanically dividing the total by the number of visits.
If part of the payment is a genuine completion incentive
Separate it from prorated reimbursement and compensation and evaluate its size and conditions for possible undue influence.

This structure also answers much of the related question of what participants should receive after withdrawal. Instead of negotiating after someone leaves, researchers can consult the payment schedule and determine what has already accrued.

07 · A Quick Checklist

Before Using Prorated Participant Payment

Check:
Separate reimbursement, compensation, and genuine incentive payments before designing the proration schedule.
Identify the meaningful units of participation through which payment accrues.
Base reimbursement on qualifying expenses actually incurred rather than an arbitrary study-completion percentage.
Account for differences in time, effort, inconvenience, or burden among study activities.
Avoid withholding most ordinary compensation until the final visit without a defensible reason.
Distinguish payment accrual from the administrative date on which money is disbursed.
Define prospectively what happens if a participant withdraws or is removed from the study.
State the payment amount, schedule, and conditions clearly in consent materials and obtain required ethics approval.
08 · Frequently Asked Questions

Frequently Asked Questions About Prorated Research Payment

What does prorated participant payment mean?

It means that reimbursement or compensation accrues according to the portion or activities of research actually completed rather than requiring full study completion before ordinary payment is earned.

If someone completes half the study, should they receive exactly half the payment?

Only when half the study represents roughly half of the relevant compensable contribution. Different visits may involve different time or burdens, and reimbursement should reflect actual qualifying expenses rather than a simple percentage.

Does FDA require payment to accrue during a study?

FDA guidance states that payment credit should accrue as the study progresses and should not be contingent on completion of the entire study. It also permits a reasonable small proportion to function as a completion incentive.

Can researchers pay all accrued amounts at the end even if payment is prorated?

Sometimes. FDA and SACHRP recognize that delayed disbursement can be administratively reasonable, particularly in short studies, provided accrued payment is preserved and the timing does not create undue inconvenience or coercive pressure.

Can a completion bonus be excluded from proration?

Potentially. SACHRP recommends prorating reimbursement and compensation but recognizes that a genuine incentive may be contingent on reaching a completion milestone. FDA likewise permits a reasonable small completion incentive that is not so large as to unduly induce continued participation.

Can researchers reduce prorated payment if a participant did not follow instructions?

That should not be improvised after participation. Payment conditions should be prospectively defined, ethically justified, and disclosed. Whether researchers may withhold payment when study instructions are not followed depends on what the payment represents and what conditions were legitimately established beforehand.

Can payment be prorated for an incomplete survey?

Potentially, if the approved payment structure legitimately ties compensation to completed portions or defined milestones. Researchers should avoid inventing post hoc deductions simply because incomplete data are less useful than expected.

09 · The Bottom Line

Prorate According to What Participants Actually Contribute

The Bottom Line

Research reimbursement and compensation can generally be prorated according to expenses incurred and participation completed, and doing so helps prevent ordinary payment from becoming leverage against a participant's right to withdraw.

Proration need not mean dividing the total payment mechanically by the number of visits. Build the schedule around actual costs, time, activities, and burdens, while keeping any genuine completion incentive distinct and prospectively defined.

10 · Sources and Further Reading

Authoritative Guidance on Prorated Participant Payment

11 · Cite this Guide

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.

Has the Field Guide helped your research?

If a guide helped clarify a question, inform a research decision, or move your work forward, I would love to hear about your experience. Your story may also help other researchers discover the Field Guide.

Share Your Experience
Takes only a few minutes